Position
Chief Technology Officer
Company
RYNE Biotechnology
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Kenai Therapeutics announced the appointment of Derek Hei, Ph.D., as chief technology officer. Dr. Hei will oversee the advancement of the company’s pipeline, including the lead candidate RNDP-001, a dopaminergic progenitor cell therapy designed to replace neurons lost due to neurodegeneration
Quick answer
Kenai Therapeutics Appoints Derek Hei as Chief Technology Officer (October 23, 2024). RYNE Biotechnology is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Technology Officer at RYNE Biotechnology?
- RYNE Biotechnology named Derek Hei Chief Technology Officer, announced October 23, 2024.
- What did RYNE Biotechnology announce on October 23, 2024?
- Kenai Therapeutics announced the appointment of Derek Hei, Ph.D., as chief technology officer.
- What does RYNE Biotechnology do?
- Kenai Therapeutics is also known as Ryne Biotechnology.
- Where is RYNE Biotechnology based?
- RYNE Biotechnology is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- LigaChem Biosciences (October 23, 2024), Parexel (October 22, 2024), Arialys Therapeutics (October 22, 2024) and ME Therapeutics Holdings (October 25, 2024) also announced leadership changes within 45 days of RYNE Biotechnology.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- LigaChem Biosciences Appoints Rodrigo Ruiz Soto as Chief Medical Officer (CMO) (October 23, 2024)
- Parexel Appoints Keri Mattox as Chief Business Officer (October 22, 2024)
- Arialys Therapeutics Appoints Dr. Sankalp Gokhale as Chief Medical Officer (October 22, 2024)
- ME Therapeutics Appoints Karim Lalji as Chief Business Officer (October 25, 2024)
- HuidaGene Therapeutics Appoints TJ Cradick, PhD as Chief Technology Officer (October 21, 2024)
- Actinogen Medical Appoints Andrew Udell as Chief Commercial Officer reporting to CEO Dr Steven Gourlay (October 29, 2024)
Who to call at RYNE Biotechnology, and when
A new leader at RYNE Biotechnology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day RYNE Biotechnology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RYNE Biotechnology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RYNE Biotechnology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RYNE Biotechnology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
RYNE Biotechnology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.